Levofloxacin, Chronic Bacterial Prostatitis

Status Completed

Clinical Trial Summary

Primary objective:

- To investigate the microbiological efficacy, assessed as eradication rate based on microbiologically evaluable patients 1 month post treatment with oral Levofloxacin 500 mg in male adults with chronic bacterial prostatitis (CBP, category II)

Secondary objectives:

- To investigate the microbiological efficacy, assessed as eradication rate based on microbiologically evaluable patients 6 months post treatment with oral Levofloxacin 500 mg in male adults with chronic bacterial prostatitis (CBP, category II).

- To assess the clinical response rate based on resolution of signs and symptoms after 2 weeks of treatment; 5-12 days, 1 month, 3 months and 6 months post treatment with oral Levofloxacin 500 mg in male adults with chronic bacterial prostatitis (CBP, category II).

- To assess the safety of Levofloxacin 500 mg on the basis of adverse events, standard clinical chemistry, hematology, urinalysis and vital signs in male adults with chronic bacterial prostatitis (CBP, category II).

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Prostatitis

Clinical Trial Details

NCT number	NCT00277511
Study type	Interventional
Source	Sanofi
Contact
Status	Completed
Phase	Phase 3
Start date	March 2003

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02246361` - Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication	Phase 4
Recruiting	`NCT00775515` - Laparoscopic Prostatectomy for Chronic Prostatitis	Phase 2
Withdrawn	`NCT03027076` - Microbiome of Urologic Chronic Pelvic Pain Syndrome	N/A
Completed	`NCT00402688` - An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis	Phase 3
Suspended	`NCT00194636` - Effectiveness of Sympathetic Plexus Block on Male Pelvic Pain (Prostatitis, Prostatodynia)	Phase 4
Recruiting	`NCT03720951` - Applying Pulsed Radiofrequency to the Pudendal Nerve Bilaterally Vs Its Application to Sacral Nerve Roots S2,3 and 4 Bilaterally in Chronic Prostatitis	N/A
Completed	`NCT03879486` - Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate Biopsy	N/A
Completed	`NCT01676857` - Chemokine Mechanisms in Chronic Pelvic Pain
Completed	`NCT00236808` - A Study to Evaluate the Safety and Effectiveness of Levofloxacin Compared With Ciprofloxacin in Patients With Chronic Bacterial Prostatitis	Phase 3
Completed	`NCT00169585` - Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)	Phase 3
Completed	`NCT01886547` - 2013 Annual National Digital Rectal Exam (DRE) Day Study	N/A
Completed	`NCT00701311` - An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome	Phase 2
Terminated	`NCT00194597` - Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III	Phase 4
Completed	`NCT03931538` - Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study	N/A
Completed	`NCT00675298` - Linkage Analysis in Interstitial Cystitis	N/A
Terminated	`NCT00529386` - Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)	Phase 1
Completed	`NCT00103402` - Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome	Phase 3
Completed	`NCT00260637` - Efficacy Study of Acupuncture to Relieve Symptoms of Chronic Prostatitis	Phase 2/Phase 3
Recruiting	`NCT01932645` - Etiology Study of Prostatitis
Completed	`NCT01826617` - Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome	N/A